<?xml version="1.0" encoding="UTF-8"?>
<ref id="ppat.1006932.ref034">
 <label>34</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Huttner</surname>
   <given-names>A</given-names>
  </name>, 
  <name>
   <surname>Dayer</surname>
   <given-names>JA</given-names>
  </name>, 
  <name>
   <surname>Yerly</surname>
   <given-names>S</given-names>
  </name>, 
  <name>
   <surname>Combescure</surname>
   <given-names>C</given-names>
  </name>, 
  <name>
   <surname>Auderset</surname>
   <given-names>F</given-names>
  </name>, 
  <name>
   <surname>Desmeules</surname>
   <given-names>J</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial</article-title>. 
  <source>Lancet Infect Dis</source>. 
  <year>2015</year>;
  <volume>15</volume>(
  <issue>10</issue>):
  <fpage>1156</fpage>â€“
  <lpage>66</lpage>. 
  <comment>doi: 
   <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S1473-3099(15)00154-1" xmlns:xlink="http://www.w3.org/1999/xlink">10.1016/S1473-3099(15)00154-1</ext-link>
  </comment> .
  <?supplied-pmid 26248510?>
  <pub-id pub-id-type="pmid">26248510</pub-id>
 </mixed-citation>
</ref>
